{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:46:44Z","timestamp":1793252804486,"version":"4.5.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Sciences University Scientific Research Coordination Unit","award":["2019\/115"],"award-info":[{"award-number":["2019\/115"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"abstract":"<jats:p>\n                    Breast cancer is one of the most common cancers in women worldwide. Several therapy modalities have been created recently; however, resistance to therapy is a major issue. Cancer stem cell functions and regulations are important in tumor progression, invasion, metastasis, and therapy resistance. The expression levels of cancer stem cell genes\n                    <jats:italic toggle=\"yes\">CD44<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">CD24<\/jats:italic>\n                    , and related miRNAs miR590-3p, miR599, and miR399-3p were aimed to be investigated before and after neoadjuvant therapy in breast cancer patients in this cross-sectional observational study. This study included 80 samples from 40 female patients. The expression of\n                    <jats:italic toggle=\"yes\">CD44<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">CD24<\/jats:italic>\n                    genes and miR590-3p, miR599, and miR399-3p was analyzed by qPCR in pre- and posttreatment biopsies from breast carcinoma patients. Correlations between expression levels and other pathologic parameters, including molecular subtypes, grade, stage, metastasis, recurrence, pathologic response to therapy, and disease-free and overall survival, were investigated.\n                    <jats:italic toggle=\"yes\">CD44<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">CD24<\/jats:italic>\n                    mRNA expression levels decreased significantly after treatment. However, miR590-3p expression increased after treatment. Patients with complete pathologic responses had upregulated\n                    <jats:italic toggle=\"yes\">CD24<\/jats:italic>\n                    and downregulated miR590-3p and miR399-3p levels in initial biopsies. Univariate analysis showed that increased expression levels of miR590-3p, miR599, and miR399-3p were significantly associated with shorter disease-free survival. A better understanding of the role of cancer stem cells in cancer can result in more promising results and patient-tailored therapy options. This study highlights the significant value of cancer stem cells and related miRNAs in response to therapy and recurrence.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043077","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:00:41Z","timestamp":1751295641000},"page":"e43077","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Impact of neoadjuvant therapy on cancer stem cell gene expression and miRNA profiles in breast cancer patients: Implications for therapy resistance and survival, a cross-sectional observational study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3981-6026","authenticated-orcid":false,"given":"Tuba Dilay","family":"K\u00f6kenek \u00dcnal","sequence":"first","affiliation":[{"name":"Betul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey"},{"name":"Department of Pathology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-7382","authenticated-orcid":false,"given":"M\u00fczeyyen Burcu","family":"Kaplan Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Abdurrahman Yurtaslan Onkoloji Research and Training Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-7837","authenticated-orcid":false,"given":"Ol\u00e7ay","family":"Kandemir","sequence":"additional","affiliation":[{"name":"Department of Pathology, G\u00fclhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0894-5354","authenticated-orcid":false,"given":"Samet","family":"Yora","sequence":"additional","affiliation":[{"name":"Betul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5806-8241","authenticated-orcid":false,"given":"Serpil","family":"Taheri","sequence":"additional","affiliation":[{"name":"Betul Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey"},{"name":"Department of Molecular Biology and Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260813","first-page":"12","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"102793","DOI":"10.1016\/j.amsu.2021.102793","article-title":"Breast cancer resistance to chemotherapy: when should we suspect it and how can we prevent it?","volume":"70","author":"Prihantono","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"106535","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: biology, biomarkers, and treatments.","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1177\/15353702211005390","article-title":"Cancer and stem cells.","volume":"246","author":"Yin","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"R5-20260813","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4252\/wjsc.v7.i8.1078","article-title":"Emerging role of microRNAs in cancer stem cells: implications in cancer therapy.","volume":"7","author":"Garg","year":"2015","journal-title":"World J Stem Cells"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-018-05085-9","article-title":"Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.","volume":"174","author":"Joseph","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/his.12868","article-title":"Breast cancer stem cells: are we ready to go from bench to bedside?","volume":"68","author":"Lin","year":"2016","journal-title":"Histopathology"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"45370","DOI":"10.18632\/oncotarget.9659","article-title":"The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5152\/tjbh.2015.1669","article-title":"Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way.","volume":"11","author":"Eliyatkin","year":"2015","journal-title":"J Breast Heal"},{"key":"R11-20260813","first-page":"11287","article-title":"Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.prp.2015.05.011","article-title":"The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast. CD44\/CD24 expression in breast cancer.","volume":"211","author":"Kapucuo\u011flu","year":"2015","journal-title":"Pathol Res Pract"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/ijpm.ijpm_437_21","article-title":"Role of CD44 as cancer stem cell marker in triple-negative breast cancer and its association with histological grade and angiogenesis.","volume":"66","author":"Tomar","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-015-0486-9","article-title":"Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.","volume":"13","author":"Han","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.2011.090456","article-title":"Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.","volume":"64","author":"Ricardo","year":"2011","journal-title":"J Clin Pathol"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1541-7786.MCR-11-0156","article-title":"Understanding the dual nature of CD44 in breast cancer progression.","volume":"9","author":"Louderbough","year":"2011","journal-title":"Mol Cancer Res"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BD-190409","article-title":"Role of CD44 in breast cancer.","volume":"39","author":"Al-Othman","year":"2020","journal-title":"Breast Dis"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2147\/OTT.S180972","article-title":"Effect of CD44st and HER2 expression on the postoperative prognosis of breast cancer patients.","volume":"12","author":"Chen","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s13193-024-02013-w","article-title":"Expression of cancer stem cell markers (CD24, CD44, and ALDH1A3 isoform) in Breast Cancer in Indian population considering clinicopathological characteristics and response to neoadjuvant chemotherapy \u2013 a prospective analysis from a university hospital.","volume":"15","author":"Ansari","year":"2024","journal-title":"Indian J Surg Oncol"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00423-023-03100-2","article-title":"Oncological recurrence following pathological complete response after neoadjuvant treatment in patients with esophageal cancer \u2014 a retrospective cohort study.","volume":"408","author":"Hipp","year":"2023","journal-title":"Langenbecks Arch Surg"},{"key":"R21-20260813","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41523-023-00525-2","article-title":"Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.","volume":"9","author":"Huober","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"R22-20260813","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cancers12040879","article-title":"Revisiting cancer stem cells as the origin of cancer-associated cells in the tumor microenvironment: a hypothetical view from the potential of iPSCs.","volume":"12","author":"Osman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R23-20260813","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1038\/s41598-017-13460-7","article-title":"Mesenchymal stem cells from tumor microenvironment favour breast cancer stem cell proliferation, cancerogenic and metastatic potential, via ionotropic purinergic signalling.","volume":"7","author":"Maffey","year":"2017","journal-title":"Sci Rep"},{"key":"R24-20260813","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1038\/s41598-017-14364-2","article-title":"Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"R25-20260813","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/BD-200441","article-title":"Expression analysis of CD24 and CD44 transcripts in Iranian breast cancer patients.","volume":"39","author":"Liaghati","year":"2020","journal-title":"Breast Dis"},{"key":"R26-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-015-0589-9","article-title":"CD24+ cells fuel rapid tumor growth and display high metastatic capacity.","volume":"17","author":"Rostoker","year":"2015","journal-title":"Breast Cancer Res"},{"key":"R27-20260813","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/jpm12081235","article-title":"CD24: a novel target for cancer immunotherapy.","volume":"12","author":"Panagiotou","year":"2022","journal-title":"J Pers Med"},{"key":"R28-20260813","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000491667","article-title":"CD24 is a potential biomarker for prognosis in human breast carcinoma.","volume":"48","author":"Jing","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R29-20260813","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.2147\/CMAR.S176654","article-title":"CD24 expression and stem-associated features define tumor cell heterogeneity and tumorigenic capacities in a model of carcinogenesis.","volume":"10","author":"Ortiz-Montero","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R30-20260813","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4103\/ijpm.ijpm_1274_21","article-title":"Stem cell markers: a guide to neoadjuvant therapy in breast carcinomas.","volume":"66","author":"Gucin","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"key":"R31-20260813","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.18632\/oncotarget.16203","article-title":"CD24 expression and differential resistance to chemotherapy in triple-negative breast cancer.","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"key":"R32-20260813","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.phrs.2018.10.011","article-title":"Therapy-induced enrichment of cancer stem-like cells in solid human tumors: where do we stand?","volume":"137","author":"Martins-Neves","year":"2018","journal-title":"Pharmacol Res"},{"key":"R33-20260813","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3892\/or.2022.8441","article-title":"Loss of CD24 promotes radiation- and chemo-resistance by inducing stemness properties associated with a hybrid E\/M state in breast cancer cells.","volume":"49","author":"Bontemps","year":"2023","journal-title":"Oncol Rep"},{"key":"R34-20260813","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jso.10079","article-title":"Prognostic value of c-erbB2 expression in breast cancer.","volume":"79","author":"Tsutsui","year":"2002","journal-title":"J Surg Oncol"},{"key":"R35-20260813","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.breast.2010.08.001","article-title":"Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status.","volume":"20","author":"Kim","year":"2011","journal-title":"Breast"},{"key":"R36-20260813","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1080\/21655979.2021.1977555","article-title":"Long non-coding RNA (LncRNA) CASC9\/microRNA(miR)-590-3p\/sine oculis homeobox 1 (SIX1)\/NF-\u03baB axis promotes proliferation and migration in breast cancer.","volume":"12","author":"Chang","year":"2021","journal-title":"Bioengineered"},{"key":"R37-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4031-4","article-title":"ATF-3\/miR-590\/GOLPH3 signaling pathway regulates proliferation of breast cancer.","volume":"18","author":"Song","year":"2018","journal-title":"BMC Cancer"},{"key":"R38-20260813","doi-asserted-by":"crossref","first-page":"58061","DOI":"10.18632\/oncotarget.19487","article-title":"MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway.","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"R39-20260813","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.2147\/CMAR.S249576","article-title":"Effect of LINC00657 on apoptosis of breast cancer cells by regulating mir-590-3p.","volume":"12","author":"Shan","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R40-20260813","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.omtn.2020.11.003","article-title":"Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer.","volume":"24","author":"Chen","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"R41-20260813","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tjog.2021.11.010","article-title":"Downregulation of miR-599 predicts poor outcome in cervical cancer patients and promotes the progression of cervical cancer.","volume":"61","author":"Gong","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R42-20260813","first-page":"6701","article-title":"Overexpression of miR-599 is associated with metastasis in colorectal cancer via inhibition of SATB2.","volume":"10","author":"Gu","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"R43-20260813","doi-asserted-by":"crossref","first-page":"39891","DOI":"10.18632\/oncotarget.5359","article-title":"INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.","volume":"6","author":"Chi","year":"2015","journal-title":"Oncotarget"},{"key":"R44-20260813","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.3892\/ol.2017.6651","article-title":"Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancer.","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol Lett"},{"key":"R45-20260813","doi-asserted-by":"crossref","first-page":"4279039","DOI":"10.1155\/2021\/4279039","article-title":"CeRNAs in cancer: mechanism and functions in a comprehensive regulatory network.","volume":"2021","author":"Yang","year":"2021","journal-title":"J Oncol"},{"key":"R46-20260813","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/ijms24010249","article-title":"Low sulfur amino acid, high polyunsaturated fatty acid diet inhibits breast cancer growth.","volume":"24","author":"Turchi","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:02:07Z","timestamp":1786633327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":45,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043077","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}